MEP37508A - Process for the preparation of mesylates of piperazine derivatives - Google Patents

Process for the preparation of mesylates of piperazine derivatives

Info

Publication number
MEP37508A
MEP37508A MEP-375/08A MEP37508A MEP37508A ME P37508 A MEP37508 A ME P37508A ME P37508 A MEP37508 A ME P37508A ME P37508 A MEP37508 A ME P37508A
Authority
ME
Montenegro
Prior art keywords
mesylates
preparation
piperazine derivatives
relates
piperazine
Prior art date
Application number
MEP-375/08A
Other languages
Bosnian (bs)
English (en)
Croatian (hr)
Inventor
Marcel P M Van Aar
Stefanus J Schouten
Jan Zorgdrager
Michiel C Heslinga
Original Assignee
Solvay Pharm Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solvay Pharm Bv filed Critical Solvay Pharm Bv
Publication of MEP37508A publication Critical patent/MEP37508A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MEP-375/08A 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives MEP37508A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200534 2001-02-16
PCT/EP2002/001666 WO2002066449A2 (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Publications (1)

Publication Number Publication Date
MEP37508A true MEP37508A (en) 2011-02-10

Family

ID=8179894

Family Applications (1)

Application Number Title Priority Date Filing Date
MEP-375/08A MEP37508A (en) 2001-02-16 2002-02-14 Process for the preparation of mesylates of piperazine derivatives

Country Status (34)

Country Link
US (1) US7030241B2 (de)
EP (1) EP1362040B1 (de)
JP (1) JP4328528B2 (de)
KR (2) KR100859106B1 (de)
CN (1) CN1176079C (de)
AR (1) AR034206A1 (de)
AT (1) ATE284875T1 (de)
AU (1) AU2002250962B2 (de)
BG (1) BG66101B1 (de)
BR (1) BR0205683A (de)
CA (1) CA2422703C (de)
CZ (1) CZ301780B6 (de)
DE (1) DE60202261T2 (de)
DK (1) DK1362040T3 (de)
DZ (1) DZ3489A1 (de)
ES (1) ES2230481T3 (de)
HR (1) HRP20030610B1 (de)
HU (1) HUP0400772A3 (de)
IL (1) IL153509A (de)
IS (1) IS2417B (de)
ME (1) MEP37508A (de)
MX (1) MXPA03002359A (de)
MY (1) MY130687A (de)
NO (1) NO324460B1 (de)
NZ (1) NZ524632A (de)
PL (1) PL208363B1 (de)
PT (1) PT1362040E (de)
RS (1) RS51126B (de)
RU (1) RU2272036C2 (de)
SI (1) SI1362040T1 (de)
SK (1) SK286143B6 (de)
UA (1) UA75390C2 (de)
WO (1) WO2002066449A2 (de)
ZA (1) ZA200301590B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR045362A1 (es) * 2003-08-18 2005-10-26 Solvay Pharm Bv Forma cristalina estable de mesilato de bifeprunox (monometansulfonato de 7-[4-([1,1- bifenil] -3- ilmetil) -1- piperazinil] - 2-(3h) -benzoxazolona
US7435738B2 (en) 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7405216B2 (en) 2004-08-18 2008-07-29 Solvay Pharmaceuticals, B.V. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)
US7423040B2 (en) * 2005-02-18 2008-09-09 Irene Eijgendaal Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same
US7964604B2 (en) * 2005-02-18 2011-06-21 Solvay Pharmaceuticals B.V. Bifeprunox mesylate maintenance dose compositions and methods for using the same
US20070275977A1 (en) * 2006-05-02 2007-11-29 Van Aar Marcel P N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
US7786126B2 (en) 2006-06-16 2010-08-31 Solvay Pharmaceuticals B.V. Combination preparations comprising SLV308 and a dopamine agonist
US8106056B2 (en) 2006-06-16 2012-01-31 Solvay Pharmaceuticals B.V. Combination preparations comprising bifeprunox and a dopamine agonist
EP2059245A1 (de) 2006-08-31 2009-05-20 Solvay Pharmaceuticals B.V. Bifeprunox-dosen zur behandlung von schizophrenie
US20090068290A1 (en) * 2006-08-31 2009-03-12 Michel Bourin Bifeprunox doses for treating schizophrenia
US20080132520A1 (en) * 2006-08-31 2008-06-05 Winsemius Antje A Compositions, kits and methods for administering a titration schedule comprising bifeprunox compounds
CA2712005C (en) 2008-02-05 2014-04-15 Harbor Biosciences, Inc. Pharmaceutical solid state forms
WO2011023796A1 (en) 2009-08-31 2011-03-03 Abbott Healthcare Products B.V. Bifeprunox for treating addiction
UY32935A (es) 2009-10-12 2011-05-31 Abbott Healthcare Products Bv Polimorfos de pardoprunox

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0185429A1 (de) * 1984-12-21 1986-06-25 Duphar International Research B.V Bizyklische Piperazine
ATE81975T1 (de) * 1984-12-21 1992-11-15 Duphar Int Res Arzneimittel mit psychotroper wirkung.
JPH0344383A (ja) * 1989-07-12 1991-02-26 Ihara Chem Ind Co Ltd 5―トリフルオロメチル―2―ハロメチルベンゾチアゾール類の製造法
JP3044383B2 (ja) * 1990-05-22 2000-05-22 コニカ株式会社 含窒素6員環化合物の製造方法
GB9200293D0 (en) * 1992-01-08 1992-02-26 Wyeth John & Brother Ltd Piperazine derivatives
PT889889E (pt) * 1996-03-29 2007-01-31 Duphar Int Res Composto de piperazina e piperidina
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds
UA71590C2 (en) * 1998-11-13 2004-12-15 Duphar Int Res Piperazine and piperidine derivatives
US7435738B2 (en) * 2003-08-18 2008-10-14 Solvay Pharmaceuticals, Inc. Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate)

Also Published As

Publication number Publication date
CZ301780B6 (cs) 2010-06-23
ZA200301590B (en) 2004-02-05
EP1362040B1 (de) 2004-12-15
EP1362040A2 (de) 2003-11-19
DE60202261T2 (de) 2005-05-19
MY130687A (en) 2007-07-31
DE60202261D1 (de) 2005-01-20
HRP20030610B1 (en) 2006-02-28
KR100859106B1 (ko) 2008-09-18
AR034206A1 (es) 2004-02-04
ES2230481T3 (es) 2005-05-01
IL153509A (en) 2007-12-03
SI1362040T1 (en) 2005-06-30
PL208363B1 (pl) 2011-04-29
KR20030077523A (ko) 2003-10-01
WO2002066449A2 (en) 2002-08-29
NO20031754D0 (no) 2003-04-15
BR0205683A (pt) 2004-07-06
JP4328528B2 (ja) 2009-09-09
NO20031754L (no) 2003-04-15
KR101000733B1 (ko) 2010-12-14
UA75390C2 (en) 2006-04-17
ATE284875T1 (de) 2005-01-15
RU2272036C2 (ru) 2006-03-20
IS2417B (is) 2008-10-15
NO324460B1 (no) 2007-10-22
SK3092003A3 (en) 2003-09-11
NZ524632A (en) 2004-03-26
KR20080064206A (ko) 2008-07-08
CN1463268A (zh) 2003-12-24
DK1362040T3 (da) 2005-01-24
CN1176079C (zh) 2004-11-17
SK286143B6 (sk) 2008-04-07
WO2002066449A3 (en) 2002-10-24
YU64403A (sh) 2006-05-25
HUP0400772A3 (en) 2008-02-28
BG66101B1 (bg) 2011-04-29
MXPA03002359A (es) 2003-06-30
CA2422703A1 (en) 2002-08-29
BG108090A (bg) 2004-12-30
PT1362040E (pt) 2005-05-31
JP2004518741A (ja) 2004-06-24
AU2002250962B2 (en) 2006-08-24
HRP20030610A2 (en) 2005-06-30
PL369330A1 (en) 2005-04-18
IL153509A0 (en) 2003-07-06
CZ2003697A3 (cs) 2003-06-18
CA2422703C (en) 2010-04-13
IS6876A (is) 2003-07-17
RS51126B (sr) 2010-10-31
US20040077631A1 (en) 2004-04-22
HK1059934A1 (en) 2004-07-23
HUP0400772A2 (hu) 2004-08-30
US7030241B2 (en) 2006-04-18
DZ3489A1 (fr) 2002-08-29

Similar Documents

Publication Publication Date Title
IL161559A0 (en) Dibenzylamine derivatives and pharmaceutical compositions containing the same
CO5611127A2 (es) Derivados de indolilmaleimida
NO20051826L (no) Heterosyklisk substituerte piperaziner for behandling av schizofreni
HUP0401982A2 (hu) Indolizinszármazékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
NO20060219L (no) Forbindelser
YU52403A (sh) Heterociklična jedinjenja koja imaju antibakterijsko dejstvo, postupak za njihovo dobijanje i farmaceutske smeše koje ih sadrže
WO2004103977A3 (en) Process for the preparation of pyrimidine derivatives
MXPA03000161A (es) Compuestos novedosos los cuales tienen actividad antiinflamatoria, proceso para su preparacion y composiciones farmaceuticas que las contienen.
HUP9802129A1 (hu) Piperazin- és piperidinszármazékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
TNSN07006A1 (en) Novel heterocyclic compounds
YU64403A (sh) Postupak za pripremanje mezilata piperazin derivata
AU2003249484A1 (en) Novel bio-active molecules
HUP9801072A2 (hu) Szubsztituált 6-és 7-amino-tetrahidro-izokinolin-karbonsav-származékok, ezeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
AU6785201A (en) Novel pyrazinone derivatives
AU674547B2 (en) Enzymatic process for the stereoselective preparation of a hetero-bicyclic alcohol enantiomer
MXPA04000978A (es) Procedimiento para la produccion de 4-amino-2,5-bisheterociclilquinazolinas.
WO2005000804A3 (en) Substituted indoles and a process for preparing substituted indoles
HRP20020440B1 (en) 1-aza-dibenzoazulenes as inhibitors of tumor necrosis factor production and intermediates for the preparation thereof
EA200101209A1 (ru) Новые производные бензола, способ их получения и фармацевтические композиции, содержащие их
MY139258A (en) Carbamoyl-type benzofuran derivatives
NO20063111L (no) Fremgangsmate for fremstilling av tiazolpyrimidiner
MXPA03012073A (es) Amidoderivados heterociclicos.
MY140442A (en) A new process for the preparation of epothilone derivatives
MY134563A (en) Process for preparing distamycin derivatives
NO955071D0 (no) abeo-Ergolin-derivater som 5HT1A-ligander